The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling.
Wang MW; Wei S; Faccio R; Takeshita S; Tebas P; Powderly WG; Teitelbaum SL; Ross FP; The Journal Of Clinical Investigation, 2004, vol. 114, issue 2, p 206, ISSN 00219738. ISBN 00219738.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef